Actrapid Hm Penfil

Actrapid HM Penfil is a short-acting insulin produced by the Danish company Novo Nordisk.

Main characteristics:

1. Country of origin - Denmark
2. Pharm group - short-acting insulins
3. Manufacturer - Novo Nordisk A/O (Denmark)
4. International name - Soluble insulin (human genetically engineered)
5. Synonyms - Actrapid HM, Actrapid HM penfil, Biosulin R, Gansulin R, Insulin Humulin R, Insulin Humulin Regular, Human insulin, Human insulin suspension, Insuman Rapid GT, Insuran R, Humulin R, Humulin Regular, Humulin Regular
6. Dosage form - solution for injection 100IU/ml

Actrapid HM Penfil begins to act 30 minutes after injection, the peak of action is reached after 2-4 hours. The duration of action is 5-8 hours. This insulin is used to control blood sugar levels in patients with diabetes.